| Page |
|
Excess mortality blog post #16 |
COVID-19Cross-PracticeDemographyHealthcare |
| Event |
|
Webinar: Update from the COVID-19 Action Group |
COVID-19 |
| Event |
|
Webinar: The impact of COVID -19 on General Insurance |
COVID-19General Insurance |
| Event |
|
WEBINAR: Non-Life HoAF Forum – Covid 19 Implications |
COVID-19General Insurance |
| Event |
|
Update COVID-19: Medical & Epidemiological Aspects: The Onerous Way out of Lock Down |
COVID-19 |
| Event |
|
Webinar: Investing & COVID19 – An international perspective |
COVID-19Finance & InvestmentLife AssuranceLife ReinsurancePensions |
| Event |
|
Webinar: Investing & COVID19 – An Irish perspective |
COVID-19Finance & InvestmentLife AssuranceLife ReinsurancePensions |
| Event |
|
COVID-19 and Enterprise Risk Management – Perspectives on Risk Analytics, Risk Strategy, and the Role of the CRO and Centralized Risk Function within Life Insurance Companies |
COVID-19 |
| Event |
|
Webinar: Novel Coronavirus – The Impact on Life Insurance Mortality and Underwriting, and Related Modelling Challenges |
COVID-19 |
| Event |
|
Webinar: Prospects for COVID-19 Medicines |
COVID-19Cross-PracticeHealthcare |